Literature DB >> 3439810

Lead in vertebral bone biopsies from active and retired lead workers.

A Schütz1, S Skerfving, J O Christoffersson, L Ahlgren, S Mattson.   

Abstract

Samples of vertebral bone were obtained by skeletal biopsy and lead concentrations were determined by atomic absorption spectroscopy. The median level of lead in bone in 27 active lead workers was 29 micrograms/g wet weight (range 2-155), corresponding to 370 micrograms/g calcium (range 30-1,120). In 9 retired workers, the corresponding levels were 19 micrograms/g (5-76) and 250 micrograms/g calcium (60-700); in 14 reference subjects without occupational exposure, 1.3 micrograms/g (1-4) and 13 micrograms/g calcium (8-40). The bone lead content rose with time of exposure. Comparison of levels in vertebra with those in fingerbone, as measured by in vivo x-ray fluorescence in the same subjects, strongly suggested the presence of lead pools with different kinetics. The accumulation pattern, as well as the relation between levels in vertebra and fingerbone, suggests a much shorter half-time of lead in the mainly trabecular vertebral bone as compared to the mainly cortical fingerbone. Further, there was an association between vertebral and blood lead levels in the retired workers, which shows a considerable endogenous lead exposure from the skeletal pool.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3439810     DOI: 10.1080/00039896.1987.9934356

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  10 in total

1.  L-line x-ray fluorescence of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children: public health implications.

Authors:  J F Rosen; M E Markowitz; P E Bijur; S T Jenks; L Wielopolski; J A Kalef-Ezra; D N Slatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 2.  Metabolic abnormalities in lead toxic children: public health implications.

Authors:  J F Rosen
Journal:  Bull N Y Acad Med       Date:  1989-12

3.  Predictors of DMSA chelatable lead, tibial lead, and blood lead in 802 Korean lead workers.

Authors:  A C Todd; B K Lee; G S Lee; K D Ahn; E L Moshier; B S Schwartz
Journal:  Occup Environ Med       Date:  2001-02       Impact factor: 4.402

4.  Lead in finger bone, whole blood, plasma and urine in lead-smelter workers: extended exposure range.

Authors:  Andrejs Schütz; Martin Olsson; Anker Jensen; Lars Gerhardsson; Jimmy Börjesson; Sören Mattsson; Staffan Skerfving
Journal:  Int Arch Occup Environ Health       Date:  2005-01-26       Impact factor: 3.015

5.  Bone-lead analysis: development of analytical methodology for milligram samples.

Authors:  K S Subramanian; J W Connor; J C Meranger
Journal:  Arch Environ Contam Toxicol       Date:  1993-05       Impact factor: 2.804

6.  Blood lead changes during pregnancy and postpartum with calcium supplementation.

Authors:  Brian L Gulson; Karen J Mizon; Jacqueline M Palmer; Michael J Korsch; Alan J Taylor; Kathryn R Mahaffey
Journal:  Environ Health Perspect       Date:  2004-11       Impact factor: 9.031

Review 7.  Toxicokinetics of bone lead.

Authors:  M B Rabinowitz
Journal:  Environ Health Perspect       Date:  1991-02       Impact factor: 9.031

8.  The independent contribution of bone and erythrocyte lead to urinary lead among middle-aged and elderly men: the normative aging study.

Authors:  S W Tsaih; J Schwartz; M L Lee; C Amarasiriwardena; A Aro; D Sparrow; H Hu
Journal:  Environ Health Perspect       Date:  1999-05       Impact factor: 9.031

9.  Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.

Authors:  J F Rosen; M E Markowitz; P E Bijur; S T Jenks; L Wielopolski; J A Kalef-Ezra; D N Slatkin
Journal:  Environ Health Perspect       Date:  1991-02       Impact factor: 9.031

10.  Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.

Authors:  J F Rosen; M E Markowitz; P E Bijur; S T Jenks; L Wielopolski; J A Kalef-Ezra; D N Slatkin
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.